Short answer
ACTUATE THERAPEUTICS, INC. (ACTU) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). $9.96 million net proceeds from sale of 30,985,900 shares and warrants, providing near-term funding.
ACTUATE THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $9.96 million net proceeds from sale of 30,985,900 shares and warrants, providing near-term funding
- Offering structure: two shares plus one warrant at $0.71, implying substantial equity dilution for existing holders
- Common Warrants cover 15,492,950 shares at $0.45, exercisable immediately and expiring five years after issuance
- 45-day over-allotment option for 4,647,885 shares and warrants covering 2,323,942 shares, creating additional dilution risk
- Underwriter warrants equal 3.5% of shares sold, exercisable at $0.44375 beginning 180 days after issuance
Item 8.01 · Other Events
- Actuate Therapeutics priced a securities offering on October 27, 2026
- Offering terms and proceeds require review of press release Exhibit 99.1
- Updated Greenberg Traurig legal opinion supports the offering’s securities registration
- Financing may affect capital structure and shareholder dilution, depending on Exhibit 99.1 terms
Item EX-99.1 · Exhibit EX-99.1
- $11.0M gross equity financing, supporting working capital and general corporate purposes
- 30,985,900 shares issued with 15,492,950 immediately exercisable warrants, creating substantial dilution risk
- Warrants carry a $0.45 exercise price and expire five years after issuance
- Potential additional $7.0M cash proceeds if all warrants are exercised, with no assurance of exercise
- 45-day underwriter option for 4,647,885 additional shares and warrants covering 2,323,942 shares
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACTUATE THERAPEUTICS, INC. 8-K filings
Get the next ACTU 8-K as it lands
Follow ACTU for push alerts, or ask the research agent what this filing means.